Church & Dwight Co
About: Church & Dwight is the leading global producer of baking soda. Its portfolio extends beyond its legacy category to include laundry products, cat litter, oral care, deodorant, and nasal care, all sold under the Arm & Hammer brand. Its mix also includes Batiste, OxiClean, Vitafusion, Waterpik, Hero, and TheraBreath, which together with Arm & Hammer constitute around 70% of its annual sales and profits. Even as it works to grow the reach of its products, Church & Dwight still derives around 80% of its sales from its home market in the US.
Employees: 5,750
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
48% more first-time investments, than exits
New positions opened: 114 | Existing positions closed: 77
2% more funds holding
Funds holding: 1,012 [Q3] → 1,033 (+21) [Q4]
5% more capital invested
Capital invested by funds: $22B [Q3] → $23.1B (+$1.09B) [Q4]
0.59% more ownership
Funds ownership: 85.92% [Q3] → 86.51% (+0.59%) [Q4]
10% less repeat investments, than reductions
Existing positions increased: 346 | Existing positions reduced: 384
10% less funds holding in top 10
Funds holding in top 10: 10 [Q3] → 9 (-1) [Q4]
52% less call options, than puts
Call options by funds: $23.4M | Put options by funds: $49.2M
Research analyst outlook
9 Wall Street Analysts provided 1 year price targets over the past 3 months
9 analyst ratings
UBS Peter Grom 42% 1-year accuracy 11 / 26 met price target | 7%upside $110 | Neutral Maintained | 17 Apr 2025 |
B of A Securities Anna Lizzul 25% 1-year accuracy 2 / 8 met price target | 21%upside $125 | Buy Upgraded | 15 Apr 2025 |
Barclays Lauren Lieberman 52% 1-year accuracy 48 / 92 met price target | 9%downside $94 | Underweight Maintained | 11 Apr 2025 |
JP Morgan Andrea Teixeira 44% 1-year accuracy 28 / 64 met price target | 5%downside $98 | Underweight Maintained | 11 Apr 2025 |
Wells Fargo Chris Carey 51% 1-year accuracy 26 / 51 met price target | 16%upside $120 | Overweight Maintained | 2 Apr 2025 |
Financial journalist opinion
Based on 4 articles about CHD published over the past 30 days









